CO-EVOLVED MOLECULES Trademark

Trademark Overview

On Friday, March 26, 2021, a trademark application was filed for CO-EVOLVED MOLECULES with the United States Patent and Trademark Office. The USPTO has given the CO-EVOLVED MOLECULES trademark a serial number of 90605032. The federal status of this trademark filing is FOURTH EXTENSION - GRANTED as of Thursday, August 1, 2024. This trademark is owned by Empress Therapeutics, Inc.. The CO-EVOLVED MOLECULES trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations and therapeutic pharmaceuticals, both for the treatment of cancer, immune system-related diseases and disorders, endocrinological diseases and disorders, metabolic diseases and disorders, neurological diseases and disorders, and neurodegenerative diseases and disorders
co-evolved molecules

General Information

Serial Number90605032
Word MarkCO-EVOLVED MOLECULES
Filing DateFriday, March 26, 2021
Status733 - FOURTH EXTENSION - GRANTED
Status DateThursday, August 1, 2024
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, June 14, 2022

Trademark Statements

Goods and ServicesPharmaceutical preparations and therapeutic pharmaceuticals, both for the treatment of cancer, immune system-related diseases and disorders, endocrinological diseases and disorders, metabolic diseases and disorders, neurological diseases and disorders, and neurodegenerative diseases and disorders
NOT AVAILABLE"MOLECULES"

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateThursday, July 1, 2021
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameEmpress Therapeutics, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressCambridge, MA 02142
Party NameEmpress Therapeutics, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressCambridge, MA 02142

Trademark Events

Event DateEvent Description
Thursday, July 1, 2021NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Thursday, November 4, 2021ASSIGNED TO EXAMINER
Wednesday, November 24, 2021TEAS RESPONSE TO OFFICE ACTION RECEIVED
Wednesday, November 24, 2021TEAS/EMAIL CORRESPONDENCE ENTERED
Friday, November 5, 2021NON-FINAL ACTION WRITTEN
Friday, November 5, 2021NON-FINAL ACTION E-MAILED
Friday, November 5, 2021NOTIFICATION OF NON-FINAL ACTION E-MAILED
Wednesday, November 24, 2021CORRESPONDENCE RECEIVED IN LAW OFFICE
Monday, November 29, 2021NOTIFICATION OF FINAL REFUSAL EMAILED
Monday, November 29, 2021FINAL REFUSAL WRITTEN
Monday, November 29, 2021FINAL REFUSAL E-MAILED
Monday, May 9, 2022TEAS REQUEST FOR RECONSIDERATION RECEIVED
Monday, May 9, 2022CORRESPONDENCE RECEIVED IN LAW OFFICE
Monday, May 9, 2022TEAS/EMAIL CORRESPONDENCE ENTERED
Tuesday, May 10, 2022APPROVED FOR PUB - PRINCIPAL REGISTER
Tuesday, June 14, 2022PUBLISHED FOR OPPOSITION
Wednesday, May 25, 2022NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, June 14, 2022OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, August 9, 2022NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Monday, February 6, 2023SOU EXTENSION 1 FILED
Monday, February 6, 2023SOU TEAS EXTENSION RECEIVED
Monday, February 6, 2023SOU EXTENSION 1 GRANTED
Thursday, August 3, 2023SOU TEAS EXTENSION RECEIVED
Thursday, August 3, 2023SOU EXTENSION 2 FILED
Thursday, August 3, 2023SOU EXTENSION 2 GRANTED
Wednesday, February 8, 2023NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Saturday, August 5, 2023NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, February 6, 2024SOU TEAS EXTENSION RECEIVED
Tuesday, February 6, 2024SOU EXTENSION 3 FILED
Tuesday, February 6, 2024SOU EXTENSION 3 GRANTED
Thursday, February 8, 2024NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, August 1, 2024SOU TEAS EXTENSION RECEIVED
Thursday, August 1, 2024NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, February 10, 2025SOU TEAS EXTENSION RECEIVED
Thursday, August 1, 2024SOU EXTENSION 4 GRANTED
Thursday, August 1, 2024SOU EXTENSION 4 FILED

Related Keywords

molecules evolved disorders diseases related endocrinological metabolic neurodegenerative neurological system immune therapeutic